BACKGROUND: Thymic carcinoma is a rare malignancy with little information regarding
outcomes after therapy with curative intent. We undertook a retrospective analysis of all …

BACKGROUND: Thymic carcinoma is a rare, aggressive disease with low 5-year survivals.
We undertook this study to identify factors that impact prognosis and to better define the …

Aims Thymic carcinoma is a rare and invasive mediastinal tumor, with poor prognosis. The
optimal treatment for thymic carcinoma is not well defined currently. Methods A single …

Introduction: Thymic carcinoma is a rare and aggressive thymic neoplasm. The European
Society of Thoracic Surgeons developed a retrospective database collecting patients …

Introduction Thymic carcinoma is a rare and invasive mediastinal neoplasm that often
metastasizes. It constitutes a heterogeneous group of tumors that displays different biologic …

Objective: Thymic carcinoma is treated by the same guidelines used for thymoma, despite
having a more aggressive histologic appearance and clinical course. Method: To evaluate …

Objective: We retrospectively evaluated 15 patients with thymic carcinoma treated with
various modalities and investigated overall management of this disease. Methods: From …

Objectives The objectives of this collaborative study were to characterize patients with
thymic carcinoma, their treatment patterns, and association with overall survival (OS) and …

Background The low incidence of thymic carcinoma has precluded the development of
randomized clinical trials, and present knowledge is based on small retrospective studies …

Objective Thymic carcinoma (TC) is a rare and invasive mediastinal tumor, with poor
prognosis. Most of the previous published papers are single-institution based, reporting …